Copy to clipboard 
Johnson & Johnson Medical Shanghai entered co-marketing, distribution and R&D agreements with TINAVI, allowing DePuy Synthes to promote TINAVI’s robotic applications for spine and trauma surgery in China.
The TINAVI robotic platform, to date the only arm-based robotic technology with multiple indications approved for use in spine and trauma in China, comprises a robot arm, intraoperative planning interface and integrated navigation. Navigation includes intra-operative 3D imaging, optical navigation and intra-operative screw planning. The system was approved by the National Medical Products Administration in 2016.
The agreement with TINAVI supports Johnson & Johnson’s initiatives to create connected digital environments that enhance surgical performance, education and monitoring.
“The signing of this agreement is an important milestone in the field of digital surgery both in China and for the DePuy Synthes business globally.” said Will Song, President of Johnson & Johnson Medical Devices China Ltd. “We will work to create an open innovation ecosystem, promote digital and technological medical innovation, provide insights for the Chinese medical industry through local collaboration, optimize patient experience, and help upgrade the health industry, so that more people can access more convenient and better medical services to achieve the great vision of ‘Healthy China 2030’.”
